Grantclosed🌐 United StatesRFA-HG-25-003

Advancing Genomic Medicine Research (R21 Clinical Trial Optional)

National Institutes of Health

Details?

Posted: Nov 19, 2024
Response deadline: Feb 11, 2025, 12:00 AM UTC
Type: Grant
Category: 93.393, 93.172
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: RFA-HG-25-003

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
United States · Jun 5, 2023
NINR Areas of Emphasis for Research to Optimize Health and Advance Health for All (R21 Clinical Trial Optional)
United States · Sep 9, 2022
Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R21 Clinical Trial Optional)
United States · Nov 6, 2017
Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 - Clinical Trial Optional)
United States · Dec 30, 2024
Advancing Research on Molecular Targets and Mechanisms that Influence the Interplay Between Sex Hormones, HIV, and Addictive Substances (R21 Clinical Trials Not Allowed)
United States · Aug 15, 2024
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional)
United States · Jun 20, 2023

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.

Raw record

{
  "id": "357236",
  "title": "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)",
  "agency": "National Institutes of Health",
  "number": "RFA-HG-25-003",
  "docType": "synopsis",
  "cfdaList": [
    "93.393",
    "93.172"
  ],
  "openDate": "11/19/2024",
  "closeDate": "02/11/2025",
  "oppStatus": "archived",
  "agencyCode": "HHS-NIH11"
}